Morning Report | SOX -8% on rate fears, risk appetite cracks into Micron earnings
$SOXX SOX -8% risk-off swing $NVDA China export checks tighten $BABA Pentagon tag challenge, June 30 $NLR DOE $17.5B nuclear loan pool $ITA Hormuz 60-day risk clock
Market Pulse
U.S.-Iran
2 events
U.S.-Iran framework faces credibility gaps over inspections and Hormuz terms as Congress signals war-powers pushback, leaving energy-transit risk tethered to a 60-day clock.
Latest Development
After Switzerland talks, Trump said Iran accepted indefinite nuclear inspections while Tehran denied, with disputes over use of unfrozen assets and potential Strait of Hormuz tolls after 60 days amid sanctions waivers.
The Senate passed a 50-48 Iran war-powers concurrent resolution directing removal of U.S. forces from hostilities; it is nonbinding but increases scrutiny of a reported ~$80B Pentagon supplemental and broader defense funding.
Our view
Near-term normalization in energy transit continues, but the framework’s credibility and unresolved Hormuz and economic terms keep a risk premium latent. Key monitor is the 60-day negotiation window, including any move toward Hormuz tolls/controls and how congressional funding/authorization pressure evolves.
What could change our view
Iran moves to impose Hormuz tolls or disrupt transit after 60 days.
Congressional actions materially constrain funding or authorization for Iran-related operations.
Tickers: $ITA, $CL=F
Macro & Policy Digest
European defense sentiment hit as Germany weighs a frigate program reset while KNDS advances a Paris-Frankfurt IPO with state ownership changes.
Latest Development
Financial Times reported Germany may drop the F126 six-ship frigate plan for eight smaller Meko A-200 vessels, implying scope reset, possible re-tendering, and uncertainty around a Rheinmetall-led role.
KNDS announced intent to proceed with a dual-listed IPO in Paris and Frankfurt with up to 20% secondary shares; Germany plans a 40% stake and France would sell 10% to match, pending budget committee action.
Market reaction
European defense sold off on contract-risk repricing: Rheinmetall fell as much as 17.3% intraday, with Hensoldt -5.1%, Renk -5.8%, Saab -3.5%, Leonardo -4.4% and BAE -1.2%; the Stoxx Europe Aerospace & Defense ETF slipped 1.9%.
Our view
Defense equities stay driven by procurement execution and backlog-conversion visibility rather than budget headlines, keeping European names and ITA sentiment-sensitive. Next watch is Germany’s budget committee actions and whether any re-scope clarifies timing, contractor roles, and KNDS IPO terms.
What could change our view
Budget committee approval delivers clear program continuity and reduces execution uncertainty quickly.
KNDS IPO terms absorb demand without weighing on listed European defense peers.
Tickers: $ITA
Semis led a sharp risk-off swing as SOX slid ~8% with rate fears resurfacing and Micron earnings now the next positioning reset point.
Latest Development
Tuesday’s de-risking hit chip/AI equities: SOX fell ~8%, MU dropped ~13% into its earnings update due today, with NVDA down >4% and INTC down ~6.1% alongside Nasdaq’s >2% decline.
Market reaction
A broad semis/AI selloff drove SOX down ~8% with MU -~13%, NVDA - >4% and INTC -~6.1%, while the Nasdaq fell >2%; in rates/FX, US 10-year yields were referenced around 4.49% and the dollar index sat near a ~13-month high.
Our view
Semis remain rate- and positioning-sensitive near term, keeping SOXX/SMH biased to elevated volatility until expectations are reset. The main watchpoint is MU results/guidance as the next read-through on AI-driven memory demand and pricing that can re-anchor the complex.
What could change our view
MU guidance materially re-accelerates demand/pricing expectations, forcing rapid risk-on re-rating.
Rates and USD roll over quickly, reversing the valuation pressure on semis.
Tickers: $SOXX
DOE rolls out a $17.5B conditional loan pool to pre-buy nuclear long-lead components, aiming to de-risk and accelerate large-reactor build timelines.
Latest Development
DOE announced a $17.5B conditional loan facility to finance long-lead nuclear components for five utility/energy-sponsored projects, potentially covering 10 large reactors, with $1B upfront equity required per project site before draws.
Our view
This program is a supportive policy catalyst for the nuclear build pipeline, but near-term investability hinges on conversion from conditional commitments into finalized loans and orders. Monitor which projects qualify and whether the required $1B equity commitments are actually funded, enabling component procurement to start.
What could change our view
Conditional loans fail to finalize, delaying procurement and undermining pipeline credibility.
Utilities/partners cannot meet the $1B upfront equity requirement per project site.
Tickers: $NLR
Company Events
Tighter U.S. export enforcement is squeezing Nvidia AI hardware flows into China while Alibaba challenges a Pentagon designation ahead of a June 30 contracting ban.
Latest Development
FT reported black-market prices in China for export-restricted Nvidia systems surged as supply routes tightened, citing DGX B300 above Rmb8M and RTX 6000 Pro up to Rmb130,000 amid U.S., Taiwanese and Malaysian scrutiny.
Alibaba filed suit in federal court challenging its U.S. Defense Department “Chinese military-linked” designation; starting June 30 the Pentagon cannot enter new contracts with listed firms, and Alibaba says the label is already constraining U.S. lobbying options.
Our view
Policy and enforcement frictions keep an overhang on China-linked tech and semis exposed to restricted China channels, sustaining headline-driven volatility rather than a clean fundamental read-through. Monitor June 30 contracting-ban implementation and any court action or enforcement updates that clarify scope and spillover.
What could change our view
Alibaba obtains court relief or designation change before the June 30 cutoff.
Enforcement actions widen re-export scrutiny and disrupt broader semiconductor supply routes.
Tickers: $NVDA, $BABA
Cerebras margin guide pressures AI compute optimism while China humanoid robot forecasts rise, keeping the AI complex split between hardware profits and automation growth.
Latest Development
Cerebras’ first post-IPO quarter showed Q1 revenue $191.1M (+92% YoY) and a narrower loss; shares fell ~10% after guiding Q2 core gross margin 36%–38% vs 46.5% in Q1.
Morgan Stanley raised its 2026 China humanoid robot shipment forecast to 50,000 units from 28,000, citing faster commercialization; it estimates a ~$2B market in 2026 growing to ~$15B by 2030.
Market reaction
CBRS slid ~10% in extended trading on the lower Q2 core gross margin guide despite strong Q1 revenue growth.
Our view
AI-linked equities remain bifurcated, with near-term valuation support hinging on credible gross-margin trajectories in compute hardware while robotics/automation themes draw incremental optimism. Monitor whether Cerebras clarifies “core” revenue timing/definitions and whether China policy support translates into commercial shipment follow-through.
What could change our view
Further gross-margin compression or revenue-definition issues undermine AI hardware confidence.
Commercial humanoid robot deployments lag forecasts despite policy support and supply-chain feedback.
Tickers: $CBRS, $BOTZ
Cboe debuts listed S&P 500-linked binary contracts as CFTC fights states over jurisdiction, putting prediction markets’ growth versus regulation in focus.
Latest Development
Cboe launched its first prediction-markets product, binary contracts tied to the Mini S&P 500 Index, now available on Interactive Brokers with Charles Schwab access planned over coming months.
The CFTC sued Kentucky after the state targeted Kalshi and Polymarket, asserting exclusive federal jurisdiction as it described 20 states in litigation and at least one state ban.
Our view
Regulated, exchange-listed event contracts should keep expanding via major brokers, with Cboe positioned to capture incremental retail engagement if distribution broadens. The next catalyst is legal clarity from multi-state litigation that determines whether access scales nationally or fragments by state.
What could change our view
Court outcomes favor states, driving a patchwork of restrictions on access.
Off-exchange platforms or new entrants capture volumes faster than listed products.
Tickers: $CBOE, $CME
Alphabet enters the Dow before Monday’s open as Verizon exits while MSCI delays South Korea upgrades and keeps Indonesia under review.
Latest Development
S&P Global said Alphabet A shares will replace Verizon in the price-weighted Dow ahead of Monday’s trading, creating a defined window for index-linked repositioning and raising the index’s mega-cap tech sensitivity.
MSCI kept South Korea classified as emerging market, citing FX and market-access barriers; it extended Indonesia’s assessment to November after a January index freeze and warned reforms could still prompt a frontier downgrade.
Market reaction
Alphabet shares rose about 1% after-hours following the Dow inclusion announcement.
Our view
Expect near-term mechanical flows around the Dow implementation to support relative demand for GOOGL and increase DIA’s tech beta. For EM trackers, assume Korea remains anchored in EM benchmarks and Indonesia uncertainty persists until November; monitor follow-through on Korea’s FX-market measures and MSCI’s accessibility assessment.
What could change our view
Dow inclusion drives less passive rebalancing than expected, limiting GOOGL/DIA impact.
MSCI accelerates Korea upgrade path or clarifies Indonesia status sooner than November.
Tickers: $GOOGL, $EEM
SpaceX upsized a $25B senior unsecured bond deal on ~$90B orders, spotlighting large-scale credit absorption and long-duration supply dynamics.
Latest Development
SpaceX increased its senior unsecured notes offering to $25B from a $20B target, priced five tranches at 5.35%–6.65%, and will use proceeds to fully repay its March $20B bridge loan.
Our view
The upsized, heavily ordered SpaceX deal is a constructive read-through for high-grade credit demand, likely keeping LQD supported despite headline supply size. Watch secondary performance and whether additional benchmark issuance follows as the key condition for any near-term spread pressure.
What could change our view
Weak secondary trading or spread widening after pricing signals demand was price-insensitive.
Follow-on mega issuance wave overwhelms absorption and pressures long-duration IG spreads.
Tickers: $LQD
Absci’s ABS-201 posts clean interim Phase 1 safety with long half-life signals, advancing into MAD cohorts ahead of 2H26/early-27 PoC timing.
Latest Development
Absci reported interim blinded SAD Phase 1/2a data for ABS-201 in 32 healthy adults across four IV dose cohorts, with no treatment-emergent SAEs and an estimated half-life of at least 65 days.
Our view
The interim safety/PK profile lowers near-term clinical downside and supports continued program progression into MAD while the stock trades on expectations for later PoC. Key monitor is confirmation of durability and tolerability as subcutaneous MAD dosing in AGA participants matures toward 2H26/early-27 readouts.
What could change our view
MAD cohorts reveal tolerability, immunogenicity, or PK issues that undermine dosing interval assumptions.
PoC timelines slip or readouts disappoint, resetting expectations built on early Phase 1 signals.
Tickers: $ABSI
Go deeper -
For intraday developments, follow our Midday posts.
For the close, the wrap, and next-day trade ideas, read the Evening Memo.
For deeper work, Forward Valuation covers multi-week single-name setups (paid subscribers only).
Deep Dive is where we publish our full thematic research for paid subscribers.
Informational only; not investment advice. Sources deemed reliable.